Ophthalmology
Unither Pharmaceuticals is involved in clinical research centered on ophthalmology, with a focus on pupil dilation for pre-operative mydriasis and diagnostic use.
- Mydriatic agents
- Pharmacodynamic effects
- Ocular administration
The sponsor’s research activity in this area reflects interest in eye care applications where controlled dilation supports clinical examination and surgical preparation.
Anterior segment care
Its funded trial activity also relates to the management of the anterior segment of the eye, where short-term pupil enlargement is relevant to routine assessment and procedural readiness.
- Pupillary response
- Diagnostic ophthalmic use
- Visual examination support
This area connects to clinical needs in ophthalmic diagnostics and perioperative eye assessment.
Combination eye therapies
The sponsor is studying fixed-dose combination therapy in an ophthalmic solution, with interest in how two mydriatic compounds work together in eye-drop form.
- Tropicamide
- Phenylephrine hydrochloride
- Fixed-dose formulation
Research in this domain is tied to the development of practical ocular formulations for use in clinical settings.
Pharmacodynamics and safety
Clinical interest extends to the pharmacodynamic profile and safety of an ophthalmic product intended to produce reliable pupil dilation.
- Ocular safety
- Drug response
- Pupil dilation performance
These research themes are relevant to evaluating tolerability and functional response in eye-drop treatments.
